General information on the use of medical cannabis:
Treatment recommendations from/for the practice
SSCM is currently working on therapy recommendations, whereby the following topics will soon be available: MS-related spasticity, fibromyalgia, dementia, tourette- and restless legs syndrome. Further recommendations are planned, such as for pain, oncology/palliative care, psychiatry, epilepsy and movement disorders.
Please contact firstname.lastname@example.org if you have an appropriate expertise or clinical experience and are interested in a cooperation. We would appreciate any active collaborative efforts.
More therapy recommendations are in preparation.
Overview of cannabis- and cannabinoid-based pharmaceutical preparations marketed in Switzerland; galenics, dosages, effects, indications, manufacturers, costs:
See website DE
Guidelines Forum Suchtmedizin Ostschweiz, Fosumos